Cargando…

Score to assess the probability of relapse in granulomatosis with polyangiitis and microscopic polyangiitis

OBJECTIVE: To develop a score assessing the probability of relapse in granulomatosis with polyangiitis (GPA) and microscopic polyangiitis (MPA). METHODS: Long-term follow-up data from GPA and MPA patients included in five consecutive randomised controlled trials were pooled. Patient characteristics...

Descripción completa

Detalles Bibliográficos
Autores principales:	Samson, Maxime, Devilliers, Hervé, Thietart, Sara, Charles, Pierre, Pagnoux, Christian, Cohen, Pascal, Karras, Alexandre, Mouthon, Luc, Terrier, Benjamin, Puéchal, Xavier, Guillevin, Loic
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2023
Materias:	Vasculitis
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10069598/ https://www.ncbi.nlm.nih.gov/pubmed/36972927 http://dx.doi.org/10.1136/rmdopen-2022-002953

Ejemplares similares

Comparative study of granulomatosis with polyangiitis subsets according to ANCA status: data from the French Vasculitis Study Group Registry
por: Puéchal, Xavier, et al.
Publicado: (2022)

Childhood-onset granulomatosis with polyangiitis and microscopic polyangiitis: systematic review and meta-analysis
por: Iudici, Michele, et al.
Publicado: (2016)

Long‐Term Safety of Rituximab in Granulomatosis With Polyangiitis and in Microscopic Polyangiitis
por: Merkel, Peter A., et al.
Publicado: (2021)

Phase IIa Global Study Evaluating Rituximab for the Treatment of Pediatric Patients With Granulomatosis With Polyangiitis or Microscopic Polyangiitis
por: Brogan, Paul, et al.
Publicado: (2021)

Efficacy and safety of rituximab in the treatment of eosinophilic granulomatosis with polyangiitis
por: Teixeira, Vítor, et al.
Publicado: (2019)

Systematic literature review informing the 2022 update of the EULAR recommendations for the management of ANCA-associated vasculitis (AAV): part 1—treatment of granulomatosis with polyangiitis and microscopic polyangiitis
por: Schirmer, Jan Henrik, et al.
Publicado: (2023)

Mepolizumab for Eosinophilic Granulomatosis With Polyangiitis: A European Multicenter Observational Study
por: Bettiol, Alessandra, et al.
Publicado: (2021)

Proteinase 3 promotes formation of multinucleated giant cells and granuloma-like structures in patients with granulomatosis with polyangiitis
por: Henderson, Scott R, et al.
Publicado: (2023)

Eosinophilic granulomatosis polyangiitis (EGPA) complicated with periaortitis, precipitating role of dupilumab? A case report a review of the literature
por: Kai, Martine, et al.
Publicado: (2023)

Rituximab vs Cyclophosphamide Induction Therapy for Patients With Granulomatosis With Polyangiitis
por: Puéchal, Xavier, et al.
Publicado: (2022)

Eosinophilic granulomatosis with polyangiitis exhibits T cell activation and IgG4 immune response in the tissue; comparison with IgG4-related disease
por: Kubo, Satoshi, et al.
Publicado: (2022)

Tracheobronchial Stenoses in Granulomatosis With Polyangiitis (Wegener's): A Report on 26 Cases
por: Girard, Charlotte, et al.
Publicado: (2015)

Serum calprotectin and renal function decline in ANCA-associated vasculitides: a post hoc analysis of MAINRITSAN trial
por: Romand, Xavier, et al.
Publicado: (2023)

Differentiating tracheobronchial involvement in granulomatosis with polyangiitis and relapsing polychondritis on chest CT: a cohort study
por: Jalaber, Carole, et al.
Publicado: (2022)

Systematic literature review informing the 2022 update of the EULAR recommendations for the management of ANCA-associated vasculitis (AAV): Part 2 - Treatment of eosinophilic granulomatosis with polyangiitis and diagnosis and general management of AAV
por: Sanchez-Alamo, Beatriz, et al.
Publicado: (2023)

Molecular targeted therapies for microscopic polyangiitis and granulomatosis with polyangiitis
por: Harigai, Masayoshi, et al.
Publicado: (2019)

Current status of the treatment of microscopic polyangiitis and granulomatosis with polyangiitis in Japan
por: Sugiyama, Koichi, et al.
Publicado: (2012)

Current therapy of granulomatosis with polyangiitis and microscopic polyangiitis: the role of rituximab
por: Geetha, Duvuru, et al.
Publicado: (2014)

Place in therapy of rituximab in the treatment of granulomatosis with polyangiitis and microscopic polyangiitis
por: Shah, Shivani, et al.
Publicado: (2015)

Role of bronchoscopy for respiratory involvement in granulomatosis with polyangiitis and microscopic polyangiitis
por: Villeneuve, Thomas, et al.
Publicado: (2023)

Pituitary Involvement in Granulomatosis With Polyangiitis: Report of 9 Patients and Review of the Literature
por: De Parisot, Audrey, et al.
Publicado: (2015)

Biomarkers Predict Relapse in Granulomatosis with Polyangiitis
por: Hogan, Patrick C. P., et al.
Publicado: (2014)

The Efficacy of Mycophenolate Mofetil in Remission Maintenance Therapy for Microscopic Polyangiitis and Granulomatosis with Polyangiitis
por: Pyo, Jung Yoon, et al.
Publicado: (2021)

Serum adipokine profiles in patients with microscopic polyangiitis and granulomatosis with polyangiitis: An exploratory analysis
por: Ahn, Sung Soo, et al.
Publicado: (2021)

Three Patterns of Cutaneous Involvement in Granulomatosis with Polyangiitis
por: Ragab, Gaafar, et al.
Publicado: (2020)

Relationship between the sialylation level of anti-proteinase 3 antibodies and the activity of granulomatosis with polyangiitis (Wegener’s disease)
por: Guilpain, Philippe, et al.
Publicado: (2011)

Hypocomplementemia is associated with worse renal survival in ANCA-positive granulomatosis with polyangiitis and microscopic polyangiitis
por: Deshayes, Samuel, et al.
Publicado: (2018)

A rare case report of polyangiitis overlap syndrome: granulomatosis with polyangiitis and eosinophilic granulomatosis with polyangiitis
por: Quan, Michele V., et al.
Publicado: (2018)

Clinical characteristics of patients with granulomatosis with polyangiitis and microscopic polyangiitis in ENT practice: a comparative analysis
por: WOJCIECHOWSKA, J., et al.
Publicado: (2018)

Rituximab Biosimilar Prevents Poor Outcomes of Microscopic Polyangiitis and Granulomatosis with Polyangiitis as Effectively as Rituximab Originator
por: Kwon, Hyeok Chan, et al.
Publicado: (2020)

Development of eosinophilic granulomatosis with polyangiitis during the clinical course of microscopic polyangiitis: A case report
por: Ide, Hiroyuki, et al.
Publicado: (2022)

Penile granulomatosis with polyangiitis
por: Amico, Séverine, et al.
Publicado: (2019)

Eosinophilic Granulomatosis with Polyangiitis
por: Shukla, Ratnakar, et al.
Publicado: (2022)

Oral granulomatosis with polyangiitis
por: Tsai, Chen-Hsi, et al.
Publicado: (2023)

Fibrosis-4 index at diagnosis is associated with all-cause mortality in patients with microscopic polyangiitis and granulomatosis with polyangiitis
por: Park, Hee Jin, et al.
Publicado: (2019)

Fc receptor-like 5 and anti-CD20 treatment response in granulomatosis with polyangiitis and microscopic polyangiitis
por: Owczarczyk, Kasia, et al.
Publicado: (2020)

Granulomatosis With Polyangiitis and Microscopic Polyangiitis: A Systematic Review and Meta‐Analysis of Benefits and Harms of Common Treatments
por: Springer, Jason M., et al.
Publicado: (2021)

Vasculitis Activity-Predicting Ability of IL-12 Family Cytokines in Patients with Microscopic Polyangiitis and Granulomatosis with Polyangiitis
por: Yoon, Taejun, et al.
Publicado: (2023)

Rituximab as therapy to induce remission after relapse in ANCA-associated vasculitis
por: Smith, Rona M, et al.
Publicado: (2020)

COVID-19 and eosinophilic granulomatosis with polyangiitis or COVID-19 mimicking eosinophilic granulomatosis with polyangiitis?
por: Özdemir, Bahar, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_9jkhso2ro7q3ot5nch3rrt55r8